Our Experts
Back to all Experts
Nicholas J. Petrelli, M.D.
Director, Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute
Expertise & Research Interests
- Colorectal Cancer
- Cancer Care Management
- Cancer Detection
- Cancer clinical trials
- Surgical Oncology
Education
- MD, Tulane University Medical School
- BA, University of Notre Dame
- Surgical Oncology Fellowship, Roswell Park Cancer Institute
Nicholas J. Petrelli, M.D.
Director, Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute
Dr. Petrelli is a nationally recognized expert in colorectal cancer and a leader in advancing cancer care and research. He joined ChristianaCare in August 2001 as the Bank of America endowed medical director of the Helen F. Graham Cancer Center and Research Institute, where he led the growth of Delaware’s largest and most advanced cancer program, spanning prevention, detection, diagnosis and treatment.
Now serving as director of the Cawley Center for Translational Cancer Research, Dr. Petrelli focuses on accelerating discoveries from the lab into new therapies and clinical trials that improve patient care. Under his leadership, the Graham Cancer Center earned national distinction, including designation as a National Cancer Institute Community Oncology Research Program (NCORP) and selection as one of the original 16 NCI Community Cancer Centers Program (NCCCP) sites.
Multimedia
Experience
Petrelli receives Tilton Award from Medical Society of Delaware
Delaware-developed CRISPR cancer therapy edging closer to human testing
“It will be the first lung cancer clinical trial carried out by a gene editing program embedded in a community cancer center,” Petrelli said. “While our Gene Editing Institute has a great deal of translational research experience, this will be its first study to move scientific discovery toward an IND. And, it will also be the first time that we will be investigating technology that was grown organically at the Gene Editing Institute.”...
ChristianaCare’s Gene Editing Institute takes the next step toward its first investigational drug application for FDA approval to treat lung cancer using CRISPR
- Annals of Surgical Oncology : Associate Editor
- Surgical Oncology Clinics of North America : Editor
- Surgical Oncology : Co-Editor
- Clinical Research Award, 2014 Association of Community Cancer Centers
- American Cancer Society Clinical Oncology Fellowship Award, 1980
- American Cancer Society Clinical Oncology Fellowship Award, 1979
Nicholas J. Petrelli, M.D.
Director, Cawley Center for Translational Cancer Research, Helen F. Graham Cancer Center & Research Institute
Contact the Media Team
For the best experience in addressing your media or interview request, please use the form below, and the first available member of our media relations team will assist you.